COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 3: Articles 21-30  | Next

Effects of XFG-adapted mRNA vaccination on SARS-CoV-2 variant neutralisation
Happle, C., Hoffmann, M., Stankov, M. V., Chen, N., Nehlmeier, I., Graichen, L., Moldenhauer, A.-S., Witte, T., Pöhlmann, S., Dopfer-Jablonka, A., Behrens, G. M.
10.64898/2026.10.04.26364675 — Posted: 2026-10-06
Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses
Salomon Lopez Molina, D., Ahnou, N., Brillet, R., Delcros, J.-G., Softic, L., Jimenez Araya, B., Duval, M., Veruete, M., Bancet, A., Grenier, D., Mularoni, A., Pawlotsky, J.-M., Krimm, I., Ahmed-Belkacem, A.
10.64898/2026.10.05.756735 — Posted: 2026-10-05
C-terminal domain of SARS CoV 2 nucleocapsid protein binds transcriptional regulatory sequence RNA with high affinity and forms higher-order assemblies
Gupta, P., Singh, M.
10.64898/2026.10.02.756193 — Posted: 2026-10-05
HNRNPM promotes protein synthesis via an interaction with stem-loop 5 in the SARS-CoV-2 5'-UTR
Golagha, J., Wieja, M., Biedenkopf, N., Weigand, J. E.
10.64898/2026.10.05.756635 — Posted: 2026-10-05
Fewer Boys Were Born After Brazil's Gamma COVID-19 Wave and Pele's Death: A National Time-Series Analysis
Leite, D. F., Masukume, R., Chimberengwa, P. T., Grech, V., Mapanga, W., Masukume, G., Liczbinska, G.
10.64898/2026.09.28.26364140 — Posted: 2026-10-05
An interpretable Day-1 machine-learning model for COVID-19 mortality and severity prognosis: development in a Pakistani hospital cohort and external evaluation in Chinese and Italian populations
Jaffer, T., Aslam, S., Javaid, N., Khaliq, A., Tariq, E., Mustafa, T., Zaffar, M. A., Mirza, S.
10.64898/2026.10.01.26364553 — Posted: 2026-10-05
Vaccine attitudes and perceptions in a post-COVID Era: what lessons can be learned in Tunisia?
Ben Mansour, N., Benzina, B. F., Fray, S., Hariz, E., Gzara, A., Ben Romdhane, H., Mueller, J., Ben Miled, S.
10.64898/2026.10.02.26364577 — Posted: 2026-10-05
Male and female mice achieve equivalent protection against heterologous SARS-CoV-2 infection through divergent immune mechanisms
Kenney, D., Matsuo, M., Pantelias, A., Leger, J., Kaplan, A., Cerbo, F., Chen, D.-Y., Adams, S., Unali, G., Wallace, D., Saeed, M., Belkina, A., Harly, C., Douam, F.
10.64898/2026.09.28.755090 — Posted: 2026-10-03
The Effects of a Digital Exercise Therapy Application for Patients with Shoulder and Knee Pain During the COVID-19 Pandemic
McLaughlin, K. H., Gruner, M., Ahmadian, N., Patch, T., Zakria, B., Skolasky, R. L.
10.64898/2026.09.25.26364013 — Posted: 2026-10-01
Functional connectivity correlates of post-acute covid 19 cognitive and neuropsychiatric complications
Auwal, A. M., Keller, S., Bullmore, E., Ellul, M., Michael, B. D.
10.64898/2026.09.24.26363490 — Posted: 2026-10-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).